We found that the most aggressive subclone YTN16 expressed FGFR4 at high levels and that disruption or inhibition of FGFR4 suppressed tumor growth both in a subcutaneous and peritoneal dissemination model. This evidence concerns the gene FGFR4 and neoplasm.